Skip to main content
OpenTrials

Clinical trial condition

Hemorrhagic Disorders

Explore clinical trials studying Hemorrhagic Disorders. Study availability and eligibility vary by location and protocol.

4,580 public trials 828 recruiting studies
Refine in advanced search Browse all conditions

Hemorrhagic Disorders trial results

Active, Not Recruiting

An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial

NCT03844048

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Blood Protein Disorders, +31 more
Locations
  • University of Arizona Cancer Center - Tucson /ID# 210548 Tucson, Arizona, United States
  • UCLA Santa Monica Hematology Oncology /ID# 210551 Los Angeles, California, United States
  • Ingalls Memorial Hosp /ID# 210553 Harvey, Illinois, United States
  • Dana-Farber Cancer Institute /ID# 215360 Boston, Massachusetts, United States
View all 56 locations
View Trial Details
Active, Not Recruiting

National Cancer Institute "Cancer Moonshot Biobank"

NCT04314401

Conditions
Acute Myeloid Leukemia, Adnexal Diseases, Anatomic Stage III Breast Cancer AJCC v8, +98 more
Locations
  • Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis Daphne, Alabama, United States
  • Thomas Hospital Fairhope, Alabama, United States
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
  • Gulf Health Hospitals Inc/Infirmary Cancer Care - Saraland Saraland, Alabama, United States
View all 150 locations
View Trial Details
Active, Not Recruiting

Long-term Safety and Efficacy Study and Dose-Escalation Substudy of PF 06838435 in Individuals With Hemophilia B

NCT03307980

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • UC Davis Ellison Ambulatory Care Clinic Sacramento, California, United States
  • UC Davis Medical Center department of Radiology Sacramento, California, United States
  • UC Davis Medical Center Sacramento, California, United States
View all 25 locations
View Trial Details
Active, Not Recruiting

Efficacy and Safety of Carfilzomib in Combination With Ibrutinib vs Ibrutinib in Waldenström's Macroglobulinemia

NCT04263480

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Uniklinikum Salzburg Salzburg, Austria
  • Medizinische Universität Wien Vienna, Austria
  • Vivantes Klinikum am Urban Berlin, Germany
  • Ev. Diakoniekrankenhaus Bremen, Germany
View all 17 locations
View Trial Details
Active, Not Recruiting

Ibrutinib + Venetoclax in Untreated WM

NCT04273139

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details

Related conditions